Nov 10 (Reuters)-
Rohto Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 78.50 71.30 165.00
(+10.1 pct) (-7.8 pct) (+6.7 pct)
Operating 8.66 6.47 16.80
(+33.9 pct) (-9.9 pct) (+8.7 pct)
Recurring 8.75 6.82 16.90
(+28.3 pct) (-9.1 pct) (+5.9 pct)
Net 5.65 4.19 10.50
(+34.8 pct) (-14.0 pct) (+4.9 pct)
EPS 49.58 yen 36.83 yen 92.17 yen
EPS Diluted 49.37 yen 36.68 yen
Ann Div 21.00 yen 22.00 yen
-Q2 div 11.00 yen 10.00 yen
-Q4 div 11.00 yen 11.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T
((Tokyo Headline News Desk +813 6441 1812))